AstraZeneca, Roche-backed study supports risk-based HF screening in diabetes
Researchers say simple blood-test and echocardiography pathway could reshape diabetes-related cardiovascular care
Researchers say simple blood-test and echocardiography pathway could reshape diabetes-related cardiovascular care
The study met its primary endpoint, showing a statistically significant and clinically meaningful improvement in progression-free survival
The trial, dubbed MALBEC, marks the first in a broader late-phase development push for MK-8748, with a second NVAMD study expected to begin later this year
The new assay consolidates screening for four major viral threats into a single workflow
The timing of the partnership is crucial, as Kerala’s fertility rate has dropped to approximately 1.35–1.7 children per woman, below the replacement level of 2.1
This follows a $6 million expansion in Rosenberg in 2025 and signals a major push to boost commercial capacity, expand R&D capabilities, and meet rising demand for US-based drug product manufacturing
The newly classified assays join Roche’s Ionify 25-Hydroxy Vitamin D total assay in a growing U.S. portfolio
The Phase 2 envisionGI study is testing deudomperidone, an experimental drug aimed at treating idiopathic gastroparesis
Subscribe To Our Newsletter & Stay Updated